Abstract 4140102: Changes in EQ-5D-5L with Aficamten in Obstructive Hypertrophic Cardiomyopathy (oHCM): the SEQUOIA-HCM Trial
Year: 2024
Type: conference-abstract
Source: Circulation
Authors: Christian Schulze, Theodore Abraham, Roberto Barriales-Villa, Brian Claggett, Caroline Coats, Pablo Garcia-Pavia, Albert Hagege, James Januzzi, Ian Kulac, Raymond Kwong, Martin maron, Ahmad Masri, Michael Nassif, Iacopo Olivotto, John Spertus, Josef Veselka, Michael Butzner, Stephen Heitner, Daniel Jacoby, Stuart Kupfer, Fady Malik, Lixin Meng, Sanatan Shreay, Amy Wohltman, Mathew Maurer
Institutions: Jena University Hospital, University of California, San Francisco, Complexo Hospitalario Universitario A Coruña, Brigham and Women's Hospital, University of Glasgow, Hospital Universitario Puerta de Hierro Majadahonda, Assistance Publique – Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Massachusetts General Hospital, Lahey Hospital and Medical Center, Oregon Health & Science University, Saint Luke's Hospital, University of Missouri–Kansas City, Meyer Children's Hospital, Istituti di Ricovero e Cura a Carattere Scientifico, University Hospital in Motol, Cytokinetics (United States), Columbia University Irving Medical Center
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404246139